OVID

Ovid Therapeutics (OVID)

About Ovid Therapeutics (OVID)

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.

Details

Daily high

$1.06

Daily low

$0.99

Price at open

$1.01

52 Week High

$4.10

52 Week Low

$0.68

Market cap

70.9M

Dividend yield

0.00%

Volume

969,894

Avg. volume

303,749

P/E ratio

-2.18

Ovid Therapeutics News